Cubist Systematic Strategies, LLC Edwards Lifesciences Corp Call Options Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $1.37 Million - $1.53 Million	-16,200 Reduced 89.01%	2,000 $184,000
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $3.23 Million - $4.25 Million	-44,500 Reduced 70.97%	18,200 $1.74 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $1.85 Million - $2.33 Million	30,000 Added 91.74%	62,700 $4.78 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $1.24 Million - $1.67 Million	17,900 Added 120.95%	32,700 $2.27 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $3.73 Million - $4.32 Million	-45,800 Reduced 75.58%	14,800 $1.4 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $5.21 Million - $5.92 Million	-70,100 Reduced 53.63%	60,600 $5.01 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $6.18 Million - $7.91 Million	90,500 Added 225.12%	130,700 $9.75 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $2.78 Million - $3.63 Million	33,800 Added 528.13%	40,200 $3.32 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $553,600 - $820,928	6,400 New	6,400 $609,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.